Consistent with the provisions of this Article, the Board may regulate unique pharmacy practices including, but not limited to,  nuclear pharmacy and clinical pharmacy, to ensure the best interests of patient health and safety. (1981 (Reg. Sess., 1982), c. 1188, s. 1.)